No. Ideal Option exclusively uses secure electronic prescriptions (ePrescriptions) sent directly to your designated pharmacy.

Electronic prescribing for controlled substances (EPCS) enhances patient safety, prevents prescription loss or theft, and complies with federal regulations for managing buprenorphine and addiction treatment medications.

Evidence & Authoritative Reference: According to the Substance Abuse and Mental Health Services Administration (SAMHSA) and the DEA, electronic prescribing of buprenorphine streamlines low-barrier access to care while ensuring strict safety and regulatory oversight (SAMHSA Buprenorphine Dispensing Regulations).

Prescription supply amounts align directly with your clinical stabilization stage—starting with short 3-to-7-day supplies and progressing to 30-day supplies as recovery stability is established.

• Initial Phase (Weeks 1–2): Patients receive short-term prescriptions (every 3 to 7 days) tied to frequent follow-up visits to monitor dosing, side effects, and home stabilization.
• Stabilization Phase (Weeks 3–6): Visit and prescription schedules transition to weekly or bi-weekly intervals.
• Maintenance Phase (Long-Term): Fully stabilized patients who consistently meet recovery milestones receive 30-day prescriptions during monthly follow-up visits.

Evidence & Authoritative Reference: Clinical guidelines from NIDA and SAMHSA state that tailoring prescription supply lengths to patient stability balances safety and treatment adherence, gradually increasing patient independence as recovery progresses (NIDA Treatment Approaches for Opioid Addiction).

If you run out of medication, Ideal Option schedules a same-day or next-day emergency visit (in-person or virtual) so a provider can safely evaluate and renew your prescription.

If clinics are closed, patient care representatives submit an urgent request for a "bridge prescription" to the call provider or nurse triage team.

A bridge prescription is a short-term, emergency medication supply (up to 7 days maximum) issued to prevent sudden withdrawal when a patient cannot attend a scheduled visit.

To maintain clinical safety and adhere to federal prescribing guidelines, Ideal Option evaluates bridge prescription requests on a case-by-case basis:

• Requirement: A provider visit is always preferred. Bridge prescriptions without a live evaluation are reserved for verified emergencies.
• Clinical Criteria: Providers review patient history, including clinic visit attendance, medication adherence, and recent toxicological testing, before approving a bridge supply.
• Maximum Limit: Bridge prescriptions never exceed 7 days.

Evidence & Authoritative Reference: The U.S. Food and Drug Administration (FDA) and SAMHSA emphasize that uninterrupted buprenorphine therapy is critical to prevent opioid relapse and fatal overdose, recommending short-term bridge protocols during care transitions or emergency scheduling conflicts (FDA Buprenorphine Safety Information).

If your pharmacy experiences stock shortages, insurance delays, or refill issues, call Ideal Option Patient Care immediately at 1-877-522-1275.

Ideal Option care teams can:

• Re-route your ePrescription to an alternate local pharmacy with active inventory.
• Assist with insurance prior authorization documentation.
• Adjust your appointment schedule to resolve prescription gaps.